---
title: "LIPLASOME PHARMA ApS – CVR 29428514, financials and ownership"
description: "LIPLASOME PHARMA ApS (CVR 29428514). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Vejle. 0 employees (CVR). Gross profit -28K DKK (2025)."
canonical_url: "https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps"
locale: "en"
route_type: "company_overview"
robots: "index,follow"
---

# LIPLASOME PHARMA ApS

LIPLASOME PHARMA ApS \(CVR 29428514\). Active · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Vejle. 0 employees \(CVR\). Gross profit -28K DKK \(2025\).

CVR number: 29428514

## Company details

- **CVR number:** 29428514

- **Status:** Aktiv

- **Address:** Tabletvej 1, 7100, Vejle

- **Legal form:** Anpartsselskab \(ApS\)

- **Founded:** Feb 8, 2006

- **Employees \(CVR\):** 0

- **Production units:** 1

## Description

LiPlasome Pharma ApS har udviklet en ”drug delivery” teknologi som vha. liposomaleformuleringer af kendte anticancer stoffer sikrer en mere målrettet kræftbehandling. LiPlaCis, som er selskabets første produkt er eksklusivt licenseret til Chosa AB.

## Activities and industry

- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

- 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik

## Latest financial period

- **Reporting period:** 2025

- **Currency:** DKK

- **Gross profit:** -28,000

- **Profit after tax:** 62,000

- **Assets:** 2,389,000

- **Equity:** 2,377,000

## People

| Person | Roles | Titles |
| --- | --- | --- |
| [Hans-Henrik Horsted Eriksen](https://datapublica.dk/en/people/pid_entity_4003988239-hans-henrik-horsted-eriksen) | Board • Management | BESTYRELSESMEDLEM • ADM. DIR. |
| [John Riis Mortensen](https://datapublica.dk/en/people/pid_entity_4004084603-john-riis-mortensen) | Board | FORMAND |
| [Claus Bagger-Sørensen](https://datapublica.dk/en/people/pid_entity_4003990349-claus-bagger-s-rensen) | Reelle ejere | Reel ejer |
| [Steen Bagger-Sørensen](https://datapublica.dk/en/people/pid_entity_4003975584-steen-bagger-s-rensen) | Reelle ejere | Reel ejer |

## Auditor

| Audit firm | Auditor | Role | From |
| --- | --- | --- | --- |
| EY Godkendt Revisionspartnerselskab | Tom B. Lassen | statsaut. revisor | Mar 29, 2026 |
| — | Tobias Oppermann | statsaut. revisor | Mar 29, 2026 |

## Contact

### From [cvr.dk](https://datacvr.virk.dk/)

Advertising protected

Contact details from CVR must not be used for direct marketing when the entity is advertising protected. The protection does not cover details collected from the company’s own website. The general marketing rules still apply. [Read more at the Danish Business Authority](https://virksomhedsguiden.dk/content/ydelser/faa-reklamebeskyttet-din-virksomhed-i-cvr/3337006d-3b93-4bb0-bc08-82a0915c0332/)

Protected entities: Company

| Contact | Phone | Email |
| --- | --- | --- |
| Company | 4928\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F29428514-liplasome-pharma-aps) | — |

Branches \(1\)

LIPLASOME PHARMA ApS · Tabletvej 1 · P-1012155324

| Contact | Phone | Email |
| --- | --- | --- |
| Company | 7215\*\*\*\* [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F29428514-liplasome-pharma-aps) | bi\*\*@vecata.com [Show full](https://datapublica.dk/en/signup?redirectTo=%2Fen%2Fcompanies%2F29428514-liplasome-pharma-aps) |

## Legal owners

### Current

| Owner | Ownership | Voting rights | From |
| --- | --- | --- | --- |
| OwnerBAGGER-SØRENSEN & CO. A/S | Ownership90–99.99 % | Voting rights90 % | FromOct 14, 2022 |

### Previous

| Owner | Ownership | Voting rights | From | To |
| --- | --- | --- | --- | --- |
| OwnerVECATA INVEST ApS | Ownership90–99.99 % | Voting rights90 % | FromMay 1, 2012 | ToOct 14, 2022 |

## Beneficial owners

### Current

| Owner | Ownership | Voting rights | From |
| --- | --- | --- | --- |
| OwnerClaus Bagger-Sørensen | Ownership46.89 % | Voting rights46.89 % | FromDec 19, 2019 |
| OwnerSteen Bagger-Sørensen | Ownership46.89 % | Voting rights46.89 % | FromDec 19, 2019 |

### Previous

| Owner | Ownership | Voting rights | From | To |
| --- | --- | --- | --- | --- |
| OwnerClaus Bagger-Sørensen | Ownership42.2 % | Voting rights45.16 % | FromSep 2, 2016 | ToDec 18, 2019 |
| OwnerSteen Bagger-Sørensen | Ownership42.2 % | Voting rights45.16 % | FromSep 2, 2016 | ToDec 18, 2019 |

## Ultimate owners
[View ownership diagram](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/portfolio)
| Name | Ownership through | Calculated ownership |
| --- | --- | --- |
| Claus Bagger-Sørensen | C. Bagger-Sørensen Invest ApS → BAGGER-SØRENSEN & CO. A/S | 45–66.66 % |
| Steen Bagger-Sørensen | S. Bagger-Sørensen Invest ApS → BAGGER-SØRENSEN & CO. A/S | 45–66.66 % |

## Company pages

- [Overview](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps)

- [Financial report](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/financials)

- [Risk](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/risk)

- [Timeline](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/timeline)

- [Ownership and relations](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/portfolio)

- [Production units](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/production-units)

- [Gazelle](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/gazelle)

- [Investments](https://datapublica.dk/en/companies/29428514-liplasome-pharma-aps/investments)

## Official sources

- [Official CVR record on Virk](https://datacvr.virk.dk/enhed/virksomhed/29428514)